drugset / Trial / NCT04621799

Fibrin for Chronic Multi-level Discogenic Low Back Pain

NCT04621799

Phase 2/3 Unknown 400 enrolled Pauza, Kevin, MD
NaSingle-groupOpen-labelTreatment

Summary

Intra-annular injections of non-autologous fibrin for moderate to severe chronic low back pain (LBP).

Timeline

Start
2018-06-11
Primary completion
2020-12-31
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic Other